ALLE vs CBIO · P/E 21, rev $2.19B vs rev $1.0M
Allegion PLC (ALLE) versus Crescent Biopharma, Inc. (CBIO) — a side-by-side from cached financials, not a winner call.
Allegion PLC (ALLE) is a security & protection services company listed on US.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
ALLE currently screens at market cap $12.71B and trailing P/E 20.7. CBIO currently screens at market cap $491.3M.
Not investment advice. Open the ALLE and CBIO stock pages for the full models.
Not investment advice.